O.C. Burghuber (Vienna, Austria), W. MacNee (Edinburgh, United Kingdom)
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
M. Urban, A. Valipour, D. Kiss, P. Eickhoff, G.C. Funk, O.C. Burghuber (Vienna, Austria)
|  |
Low CT bone radio density is associated with adverse clinical features and increased coronary artery calcification in COPD
E. Romme, L. Edwards, M. Williams, J. Murchison, M. Connell, A. Agusti, S. Rennard, P. Bakke, F. Smeenk, E. Wouters, E. Rutten, W. MacNee (Eindhoven, Maastricht, Netherlands; Philadelphia, Omaha, United States Of America; Edinburgh, United Kingdom; Barcelona, Spain; Bergen, Norway)
|  |
Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
M. Williams, L. Edwards, R. Tal-Singer, B. Miller, J. Murchison, E. van Beek, D. Newby, W. MacNee (Edinburgh, United Kingdom; Philadelphia, United States Of America)
| |
Clinical impact of anaemia in patients with chronic obstructive pulmonary disease: Results from ECLIPSE study
M. Lainscak, L. Edwards, S. Anker, C. Crim, S. Rennard, E. Wouters, W. MacNee (Golnik, Slovenia; Berlin, Germany; Philadelphia, Omaha, United States Of America; Maastricht, Netherlands)
| |
Features of carbohydrate metabolism in patients with COPD
V. Kobylyansky, E. Soyustova, T. Nfnyana, B. Gulnara, Y. Suntsov, O. Pivovarova, E. Kazanseva, A. Sotnikova, N. Nina, V. Pokrovsky (Moscow, Russian Federation)
| |
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease
P. Boschetto, I. Campo, M. Stendardo, E. Casimirri, C. Tinelli, C. Ceconi, A. Fucili, A. Potena, L. Ballerin, L. M. Fabbri, M. Luisetti (Pavia, Modena, Italy)
| |
Investigation of neuromuscular transmission in patients with chronic obstructive pulmonary disease: A preliminary report
Y. Kaplan, G. Gulbas, H. Ermis, O. Kamisli, S. Kamisli, C. Ozcan (Malatya, Turkey)
| |
The impact of bacterial colonisation on airway inflammation in stable COPD
R. Singh, D. Garcha, A. Patel, A. Mackay, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
The evaluation of sensory gating with P50 paradigm in chronic obstructive pulmonary disease
O. Kamisli, H. Ermis, S. Kamisli, G. Gulbas, C. Ozcan (Malatya, Turkey)
| |
FRAX program as a method of assessing the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease
E. Kochetova (Petrozavodsk, Russian Federation)
| |
The absolute risk of osteoporotic fractures according to the program of FRAX patients with chronic obstructive pulmonary disease
E. Kochetova (Petrozavodsk, Russian Federation)
| |
Arterial stiffness and endothelial dysfunction in stable COPD patients
M. Makarova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
Evaluation of carotis intima media thickness in COPD patients
F.H. Besir, L. Yilmaz Aydin, O. Yazgan, T. Dumlu, M.E. Erkan, E. Onder, H. Coskun (Duzce, Turkey)
| |
Myocardial injuries in patients with chronic obstructive pulmonary disease
M. Kiniakin, G. Sukhanova, O. Kuraspediani (Vladivostok, Russian Federation)
| |
The metabolic syndrome (MetS) in patients with chronic obstructive pulmonary disease (COPD) and its association with airway obstruction
V. Stratev, J. Petev, S. Galcheva, M. Peneva (Varna, Bulgaria)
| |
Increased sympathetic nerve activity in COPD is associated with elevated morbidity and mortality
H. Haarmann, S. Klarner, T. Raupach, S. Andreas (Goettingen, Immenhausen, Germany)
| |